APLS
☆
EPS:
0.15
Rev:
268M
Net Inc:
19M
💾
💾
💾
💾
💾
Income Statement
Balance Sheet
Cash Flow
Revenue
vs Industry
Valuation
Overview
Income Statement
💾
Expenses
💾
Tax
💾
Assets
💾
Assets (Current)
💾
Assets (Non-Current)
💾
Liabilities
💾
Liabilities (Current)
💾
Liabilities (Non-Current)
💾
Cash Flow
💾
Cash Flow Investing
💾
Dimension Breakdowns
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
srt:ProductOrServiceAxis
Leaf Members
💾
APLS vs
Biotechnology
(37 peers) - Healthcare
Gross Margin
89.8%
+11.3pp vs peers
Operating Margin
5.5%
-31.1pp vs peers
Net Margin
2.2%
-27.7pp vs peers
ROIC
-894.9%
-952.4pp vs peers
Gross Margin
Operating Margin
Net Margin
ROIC
💾
Dimension Breakdowns
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
Leaf Members
💾
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
Leaf Members
💾
Related:
REGN
INCY
VRTX
CPRX
UTHR
ALKS
JAZZ
MRNA
PTCT
ACAD